Which procedure is considered definitive management for fibromuscular dysplasia?

The definitive management for fibromuscular dysplasia is percutaneous transluminal angioplasty. This is a minimally invasive procedure aimed at improving blood flow in the affected arteries, particularly the renal arteries, which are commonly involved in fibromuscular dysplasia.

Fibromuscular dysplasia is characterized by abnormal growth of cells in the artery wall, leading to stenosis (narrowing), aneurysms, or dissections. The primary goal of the treatment is to restore normal blood flow and reduce associated hypertension and other complications.

Percutaneous transluminal angioplasty involves the insertion of a catheter into the affected artery, where a balloon is inflated to widen the narrowed region. This method is often preferred because it preserves the arterial integrity and offers quicker recovery compared to more invasive surgical options while effectively alleviating symptoms associated with the condition.

Stenting, while sometimes utilized in vascular interventions, is not always necessary or considered definitive for fibromuscular dysplasia, as the condition can often be adequately managed with angioplasty alone. Bypass surgery and endarterectomy are typically reserved for more advanced cases or situations where angioplasty is not feasible or has failed. Therefore, percutaneous transluminal angioplasty stands out as the preferred approach for